065660 — Anterogen Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Anterogen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	50,031	47,921	59,009	55,968	50,334
Net Total Accounts Receivable
Net Total Receivables	2,605	2,166	4,907	4,196	3,923
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	54,118	54,911	65,365	62,449	56,380
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13,345	19,854	22,429	23,088	22,633
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	84,594	94,204	136,701	124,133	149,432
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14,978	11,690	13,755	15,037	10,759
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	16,200	13,137	19,834	17,341	19,987
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	68,394	81,067	116,867	106,791	129,445
Total Liabilities & Shareholders' Equity	84,594	94,204	136,701	124,133	149,432
Total Common Shares Outstanding
Total Preferred Shares Outstanding